Type 1 diabetes management and CGM integration are now on the table for WellDoc’s BlueStar, a management platform well known for being the first mobile health product to secure reimbursement as a diabetes therapy.
Thanks to a new FDA clearance, the company’s seventh, BlueStar will include integrated glucose level insights related to food, medication and activity that are based on the data from...
Livongo, the mobile-enabled diabetes management company, has raised a strategic investment from Humana to support the company’s growth. Update: Humana invested $5 million in Livongo.
Prior to this investment, Livongo has raised at least $82.5 million to date. Just last month, the company announced a $44.5 million raise. Existing investors include Merck Global Health Innovation Fund, Cowen Private...
Mountain View, California-based Livongo Health, the diabetes management company launched two years ago by former Allscripts CEO Glen Tullman, has raised $44.5 million from Merck Global Health Innovation Fund, Cowen Private Investments, Sapphire Ventures, Zaffre Investments, the investment arm of Blue Cross Blue Shield of Massachusetts, and Wanxiang America Corporation. This brings the company’s...
Baltimore, Maryland-based WellDoc has announced a collaboration with LifeScan, a Johnson and Johnson company that makes blood glucose meters. WellDoc also raised an additional $7.5 million from Johnson & Johnson Innovation and other investors, bringing the company’s total funding in its most recent round to $29.5 million.
Existing investors include Samsung Ventures, Merck Global Health...
Baltimore, Maryland-based WellDoc has raised $22 million in a round led by Samsung Ventures and Merck Global Health Innovation (GHI) Fund with participation from Adage Capital Management, Excel Venture Management, Alexandria Venture Investments and Hudson River Capital Partners.
The company will use the funds to focus on growing adoption of its flagship offering, BlueStar, an FDA-cleared mobile...
Mobile health company WellDoc's former chief strategy and commercial officer Chris Bergstrom has joined the Boston Consulting Group (BCG) as an associate director in the company's healthcare practice. Bergstrom left WellDoc, where he remains an investor, at the beginning of 2015 but served as an advisor for some months afterward.
As a member of WellDoc's founding team, Bergstrom was instrumental...
Turkish mobile operator Turkcell teamed up with Istanbul University researchers to study how its wireless-enabled diabetes device, Turkcell Healthmeter, would impact patient outcomes.
The Turkcell Healthmeter is a small, cellular-enabled device that wirelessly pairs with a number of Bluetooth-enabled blood glucose meters -- no smartphone required. For the study, the Healthmeter sent data received...
Weight Watchers announced a new weight loss program for people with type 2 diabetes, which it will provide through its employee wellness offering.
The new program, called Weight Watchers for Diabetes, will incorporate the expertise of Certified Diabetes Educators (CDE) into the company's existing weight loss and weight management system. Weight Watchers will also offer digital tools to members of...
Baltimore, Maryland-based WellDoc, one of the earliest and best known mobile health companies focused on diabetes management, has appointed Kevin McRaith as the company's new president. McRaith most recently served as VP of Sales & Marketing at Human Genome Sciences, and previously worked at Genentech, Abbott and Baxter. In this role McRaith will report to WellDoc CEO Ryan Sysko. WellDoc's...
Baltimore, Maryland-based WellDoc, one of the earliest and best known mobile health companies focused on diabetes management, has landed a $20 million round of investment that includes contributions from Merck Global Health Innovation Fund and Windham Venture Partners. The announcement marks WellDoc's first round of institutional money -- the company has long relied on angel investors and debt...
